Myrexis, Inc. (Nasdaq: MYRX) presents five posters on its novel cancer metabolism inhibitor, MPC-9528, at the 102nd annual meeting of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE